Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-02 | Future report Set alerts | |
Q2 2022 | 2022-08-04 | -0.50 | -0.50 |
Q1 2022 | 2022-05-05 | 0.40 | 0.40 |
Q4 2021 | 2022-02-23 | 0.42 | 0.42 |
Q3 2021 | 2021-11-04 | 0.18 | 0.18 |
Q2 2021 | 2021-08-05 | -0.37 | -0.37 |
Q1 2021 | 2021-05-06 | 0.00 | 0.00 |
Q4 2020 | 2021-02-23 | -0.26 | -0.26 |
Q3 2020 | 2020-11-04 | 0.17 | 0.17 |
Q2 2020 | 2020-08-06 | 0.22 | 0.22 |
2016-07-12 | Initiated Coverage | BTIG Research | Hold | |
2016-06-22 | Reiterated Rating | Wedbush | Outperform | $44.00 |
2016-06-15 | Reiterated Rating | Wedbush | Outperform | $44.00 |
2016-05-26 | Reiterated Rating | Piper Jaffray | Overweight | $41.00 |
2016-05-26 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $41.00 |
2016-05-20 | Reiterated Rating | Wedbush | Outperform | $44.00 |
2016-05-16 | Reiterated Rating | Sterne Agee CRT | Neutral | |
2016-04-30 | Reiterated Rating | Canaccord Genuity | Hold | |
2016-04-29 | Upgrade | William Blair | Market Perform to Outperform | |
2016-02-26 | Upgrade | Benchmark Co. | Hold to Buy | $30.00 to $40.00 |
2016-02-26 | Reiterated Rating | Wedbush | Outperform | $44.00 |
2016-02-26 | Lower Price Target | Canaccord Genuity | Hold | $30.00 to $28.00 |
2016-02-26 | Upgrade | Feltl & Co. | Hold to Buy | $35.00 |
2016-02-22 | Lower Price Target | Robert W. Baird | Neutral | $35.00 to $30.00 |
2016-02-03 | Lower Price Target | Robert W. Baird | Neutral | $36.00 to $35.00 |
2016-02-03 | Reiterated Rating | Canaccord Genuity | Hold | $30.00 |
2016-01-07 | Boost Price Target | Cowen and Company | $40.00 | |
2015-12-29 | Reiterated Rating | Wedbush | Buy | |
2015-12-23 | Reiterated Rating | Wedbush | Outperform | $40.00 to $44.00 |
2015-12-03 | Reiterated Rating | Northland Securities | Market Perform | |
2015-11-25 | Reiterated Rating | Wedbush | Buy | $44.00 |
2015-11-08 | Reiterated Rating | Canaccord Genuity | Hold | $30.00 |
2015-11-07 | Reiterated Rating | Wedbush | Buy | |
2015-11-06 | Boost Price Target | Wedbush | Outperform | $40.00 to $44.00 |
2015-11-06 | Boost Price Target | Cowen and Company | Outperform | $34.00 to $35.00 |
2015-11-06 | Boost Price Target | Northland Securities | Outperform | $35.00 to $40.00 |
2015-11-02 | Initiated Coverage | Morgan Stanley | Equal to Equal Weight | $32.00 |
2015-09-25 | Reiterated Rating | Wedbush | Outperform | $40.00 |
2015-08-20 | Reiterated Rating | Wedbush | Outperform | $40.00 |
2015-08-14 | Reiterated Rating | Piper Jaffray | Buy | |
2015-08-13 | Reiterated Rating | Leerink Swann | Buy | $40.00 to $44.00 |
2015-08-13 | Boost Price Target | Wedbush | $36.00 to $40.00 | |
2015-08-13 | Boost Price Target | Robert W. Baird | Neutral | $34.00 to $35.00 |
2015-08-13 | Boost Price Target | Jefferies Group | Buy | $30.00 to $39.00 |
2015-08-13 | Reiterated Rating | Canaccord Genuity | Hold | $28.00 |
2015-08-13 | Boost Price Target | Piper Jaffray | Overweight | $36.00 to $41.00 |
2015-08-13 | Downgrade | Benchmark Co. | Buy to Hold | $30.00 |
2015-07-30 | Reiterated Rating | Canaccord Genuity | Hold | $28.00 |
2015-07-30 | Upgrade | Feltl & Co. | Sell to Hold | |
2015-07-28 | Boost Price Target | JPMorgan Chase & Co. | Neutral | $26.00 to $30.00 |
2015-07-18 | Boost Price Target | Cowen and Company | $30.00 to $35.00 | |
2015-07-08 | Initiated Coverage | Robert W. Baird | Neutral | $34.00 |
2015-06-12 | Reiterated Rating | Canaccord Genuity | Hold | $28.00 |
2015-06-12 | Reiterated Rating | Jefferies Group | Buy | $30.00 |
2015-06-09 | Set Price Target | Piper Jaffray | Buy | $31.00 to $36.00 |
2015-05-09 | Reiterated Rating | Wedbush | Outperform | $38.00 to $36.00 |
2015-05-09 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $29.00 to $26.00 |
2015-05-09 | Reiterated Rating | Jefferies Group | Buy | $33.00 to $30.00 |
2015-05-09 | Reiterated Rating | Cowen and Company | Outperform | $35.00 to $30.00 |
2015-05-04 | Upgrade | Northland Securities | Market Perform to Outperform | $28.00 to $32.00 |
2015-05-01 | Lower Price Target | Canaccord Genuity | Hold | $35.00 to $28.00 |
2015-05-01 | Downgrade | Feltl & Co. | Hold to Sell | $22.75 |
2015-05-01 | Lower Price Target | Benchmark Co. | Buy | $39.00 to $30.00 |
2015-05-01 | Lower Price Target | Oppenheimer | Market Perform | $33.00 to $31.00 |
2015-05-01 | Lower Price Target | Oppenheimer Holdings Inc. | Market Perform | $33.00 to $31.00 |
2015-04-15 | Boost Price Target | Wedbush | Buy | $34.00 to $38.00 |
2015-04-14 | Reiterated Rating | Canaccord Genuity | Hold | $35.00 |
2015-03-31 | Set Price Target | Wedbush | Buy | $34.00 |
2015-03-31 | Reiterated Rating | Canaccord Genuity | Hold | $35.00 |
2015-02-27 | Reiterated Rating | Canaccord Genuity | Hold | $35.00 |
2015-02-27 | Lower Price Target | Wedbush | Outperform | $43.00 to $34.00 |
2015-02-27 | Reiterated Rating | Jefferies Group | Buy | $56.00 to $33.00 |
2015-02-27 | Downgrade | Oppenheimer | Outperform to Market Perform | $39.00 to $33.00 |
2015-02-18 | Downgrade | Canaccord Genuity | Buy to Hold | $38.00 to $35.00 |
2015-02-02 | Upgrade | Northland Securities | Under Perform to Market Perform | $28.00 |
2015-01-26 | Downgrade | William Blair | Outperform to Market Perform | |
2015-01-16 | Lower Price Target | Oppenheimer | Outperform | $50.00 to $39.00 |
2015-01-15 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $45.00 to $35.00 |
2015-01-15 | Downgrade | Raymond James | Outperform to Market Perform | |
2015-01-15 | Downgrade | Raymond James Financial Inc. | Outperform to Market Perform | |
2015-01-14 | Downgrade | Sterne Agee CRT | Buy to Neutral | |
2015-01-13 | Set Price Target | Canaccord Genuity | Buy | $38.00 |
2015-01-05 | Reiterated Rating | Jefferies Group | Buy | $50.00 to $56.00 |
2014-12-08 | Initiated Coverage | Cowen and Company | Outperform | $53.00 |
2014-11-12 | Boost Price Target | Oppenheimer | Outperform | $48.00 to $50.00 |
2014-11-06 | Reiterated Rating | JMP Securities | Market Outperform | $9.00 to $10.00 |
2014-11-06 | Reiterated Rating | Canaccord Genuity | Buy | $39.00 to $44.00 |
2014-11-04 | Initiated Coverage | Northcoast Research | Neutral | |
2014-10-27 | Initiated Coverage | Wedbush | Outperform | $46.00 |
2014-09-18 | Reiterated Rating | Off Wall Street | Sell | |
2014-08-08 | Lower Price Target | Canaccord Genuity | $40.00 to $39.00 | |
2014-05-15 | Upgrade | Barrington Research | Market Perform to Outperform | $40.00 |
2014-05-09 | Lower Price Target | Jefferies Group | $60.00 to $50.00 | |
2014-05-09 | Lower Price Target | Leerink Swann | $55.00 to $45.00 | |
2014-05-08 | Reiterated Rating | Raymond James | Outperform | $54.00 to $43.00 |
2014-05-08 | Upgrade | Feltl & Co. | Sell to Hold | |
2014-05-08 | Lower Price Target | Canaccord Genuity | $53.00 to $40.00 | |
2014-04-28 | Upgrade | Ned Davis Research | Sell to Neutral | |
2014-03-28 | Boost Price Target | Jefferies Group | $55.00 to $60.00 | |
2014-03-20 | Initiated Coverage | Sterne Agee CRT | Buy | $61.00 |
2014-02-21 | Downgrade | Feltl & Co. | Hold to Sell | $33.00 |
2014-01-24 | Boost Price Target | Canaccord Genuity | Buy | $45.00 to $53.00 |
2014-01-06 | Initiated Coverage | CRT Capital | Buy | $53.00 |
2013-11-22 | Upgrade | Raymond James | Market Perform to Outperform | $43.00 |
2013-11-08 | Boost Price Target | Jefferies Group | Buy | $38.00 to $46.00 |
2013-11-08 | Boost Price Target | Canaccord Genuity | Buy | $40.00 to $45.00 |
2013-10-15 | Initiated Coverage | Benchmark Co. | Buy | $44.00 |
2013-10-07 | Initiated Coverage | Ned Davis Research | Neutral | |
2013-09-20 | Downgrade | JMP Securities | Outperform to Market Perform | $33.00 |
2013-06-24 | Reiterated | Canaccord Genuity | Buy | $28 to $37 |
2013-06-20 | Downgrade | Feltl & Co. | Buy to Hold | $28 to $33 |
2013-06-07 | Downgrade | Wunderlich | Buy to Hold | $28 |
2012-12-21 | Reiterated | Canaccord Genuity | Buy | $24.50 to $29 |
2012-08-29 | Reiterated | Wunderlich | Buy | $22 to $24 |
2011-09-30 | Initiated | Feltl & Co. | Buy | $19.80 |
2011-09-23 | Initiated | Wunderlich | Buy | $22 |
2011-09-01 | Upgrade | JMP Securities | Mkt Perform to Mkt Outperform | $24 |
2016-07-12 | Initiated Coverage | BTIG Research | Hold | |
2016-06-22 | Reiterated Rating | Wedbush | Outperform | $44.00 |
2016-06-15 | Reiterated Rating | Wedbush | Outperform | $44.00 |
2016-05-26 | Reiterated Rating | Piper Jaffray | Overweight | $41.00 |
2016-05-26 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $41.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In PODD 329 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
FMR LLC | 10.36M |
Capital Research Global Investors | 6.46M |
Vanguard Group, Inc | 6.39M |
WELLINGTON MANAGEMENT CO LLP | 5.05M |
BlackRock Inc. | 4.81M |
Capital World Investors | 4.15M |
PRICE T ROWE ASSOCIATES INC /MD/ | 3.26M |
BlackRock Fund Advisors | 1.89M |
Clearbridge Investments, LLC | 1.66M |
BlackRock Institutional Trust Company, N.A. | 1.58M |
JPMORGAN CHASE & CO | 1.46M |
STATE STREET CORP | 1.44M |
PRIMECAP MANAGEMENT CO/CA/ | 1.17M |
AMERIPRISE FINANCIAL INC | 1.02M |
OPPENHEIMER FUNDS INC | 1.00M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
SULLIVAN PATRICK J President & CEO | 0.58% (322752) | BHLB / PKI / PODD / |
DeSisto Duane President and CEO | 0.46% (257184) | PODD / STXS / |
ROBERTS BRIAN K Chief Financial Officer | 0.21% (120050) | PODD / |
Petrovic Shacey CCO | 0.16% (89007) | PODD / |
LIAMOS CHARLES T Chief Operating Officer | 0.16% (87575) | PODD / |
Levitz Michael L CFO | 0.12% (67646) | ALOG / PODD / |
Devlin Peter Chief Commercial Officer | 0.12% (67354) | PODD / |
Thomas Bradley A EVP Human Resources | 0.12% (65818) | PODD / |
Spears Michael P SVP, Quality and Regulatory | 0.09% (51559) | PODD / |
Ryan Patrick Chief Operating Officer | 0.09% (47990) | ATEC / PODD / |
Alpuche Charles SVP, Global Manufacturing | 0.08% (42973) | PODD / |
Colleran David SVP, Secretary and GC | 0.08% (42095) | PODD / |
Diehl R Anthony Secretary and General Counsel | 0.07% (40854) | PODD / |
Dorval Allison Chief Financial Officer | 0.07% (37415) | PODD / |
Zakrzewski Joseph S | 0.05% (30558) | LPDX / PODD / SGMO / XLRN / |
Abdel-Malek Aiman SVP, Advanced Technology | 0.05% (25633) | PODD / |
CRAWFORD SALLY | 0.04% (24558) | EPRS / EXAS / HOLX / PODD / UAM / |
Wielinski Tracey Haas VP, Global Regulatory, CA, QA | 0.04% (24000) | PODD / |
SOMMER REGINA O | 0.04% (23039) | PODD / WEX / |
LEVANGIE DANIEL J | 0.04% (21122) | EXAS / LPDX / PODD / |
Scannell Timothy J | 0.03% (18639) | PODD / SYK / |
DePietro Ruthann Vice President of Quality | 0.03% (18351) | PODD / |
Hopfield Jessica | 0.03% (17937) | PODD / |
SOBIESKI STEVEN | 0.03% (16039) | PODD / ROKA / |
Benjamin Eric SVP, R&D, New Prod Dev. & Comm | 0.02% (12239) | PODD / |
Christensen Bret SVP and CCO | 0.02% (11704) | PODD / |
Fallon John A. | 0.02% (9558) | AMAG / EXAS / PODD / |
Lemoine David A | 0.02% (8398) | PODD / SCX / |
MULLEN JAMES C | 0.01% (5598) | PKI / PODD / PTHN / |
LORTZ W MARK | 0.01% (4000) | CUTR / NURO / PODD / |
MINOGUE MICHAEL R | 0.01% (3173) | PODD / |